Crossmark

GALA3-Containing Modular Nanotransporters Are Capable of Delivering Keap1 Monobody to Target Cells and Inhibiting the Formation of Reactive Oxygen Species in the Cells

Crossref DOI link: https://doi.org/10.1134/S1607672924601252

Published Online: 2025-01-31

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khramtsov, Y. V.

Bunin, E. S.

Ulasov, A. V.

Lupanova, T. N.

Georgiev, G. P.

Sobolev, A. S.
License Information

Text and Data Mining valid from 2025-01-31

Version of Record valid from 2025-01-31
More Information

Article History

Received: 10 October 2024

Revised: 21 October 2024

Accepted: 22 October 2024

First Online: 31 January 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: Animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals ( ). Animal protocols were approved by the Bioethics Committee of the Institute of Gene Biology of the Russian Academy of Sciences, Moscow, Russia (Approval ID: no. 11, March 15, 2021).

: The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below